Mark R. Hake

CFA

Mark R. Hake, CFA is a financial analyst and entrepreneur. He has been a Chartered Financial Analyst (CFA) for 31 years and has owned his own investment management and investment research firms that focused on value stocks, both in the U.S. and overseas.

Mark writes over 600 articles per year on stocks, cryptos, SPACs, convertibles, ETFs, and other financial securities. He has been ranked with 5 stars by TipRanks.com (under “Mark R. Hake”) with an average return of over 22% annually and #36 out of 8,116 writers. Presently he authors articles on Medium.com and other sites.

Mark also invests in public and private equities and has acted as a hedge fund manager and portfolio manager for various money management firms. He has also acted as CFO and Chief Strategy Officer for several fin-tech and software companies.

You can follow Mark on LinkedIn and on TipRanks .

Recent Articles

FuelCell Energy May Never Be Profitable, but FCEL Stock Is Still Up Big

By Mark R. Hake, CFA Dec 31, 2020

FuelCell Energy may never be profitable, but FCEL stock is still up big. FCEL stock continues to move higher on speculation about the benefits of the new RNG tax credit.

Fisker Stock Is On Track To Double Over the Next Year or So

By Mark R. Hake, CFA Dec 31, 2020

Fisker stock is on track to double over the next year or so. FSR stock is worth between $30.38 and $32.75, or over twice its price today.

XpresSpa Is Trying To Turn Around, But Its Legs and Arms Are Tied

By Mark R. Hake, CFA Dec 30, 2020

XpresSpa is trying to turn around, but it's tied. XSPA stock won’t be able to turn around until the company can start recognizing revenue.

Hertz Shares Are Worthless, so Don’t Be Tempted

By Mark R. Hake, CFA Dec 30, 2020

Hertz stock really is worthless, so don't be lured into buying it. Hertz stock will likely have no underlying value and be worthless when the restructuring is finished.

Lexicon Pharma Sold LXRX Stock to Weight Watchers’ Turn-Around Billionaire

By Mark R. Hake, CFA Dec 30, 2020

Lexicon Pharma sold LXRX stock to Weight Watchers' turn-around billionaire. Lexicon sold 15% of LXRX stock to Ray Debbane’s private equity company which turned Weight Watchers around.